| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Proteins | 10 | 2015 | 1850 | 0.980 |
Why?
|
| Membrane Proteins | 10 | 2007 | 2841 | 0.780 |
Why?
|
| Loss of Heterozygosity | 8 | 2013 | 605 | 0.780 |
Why?
|
| Metagenome | 2 | 2012 | 183 | 0.750 |
Why?
|
| Chromosomes, Human, Pair 11 | 10 | 1996 | 395 | 0.620 |
Why?
|
| Bacteria | 2 | 2012 | 631 | 0.590 |
Why?
|
| Metagenomics | 2 | 2012 | 120 | 0.480 |
Why?
|
| Callithrix | 1 | 2014 | 48 | 0.480 |
Why?
|
| Genes, Tumor Suppressor | 7 | 2005 | 1083 | 0.480 |
Why?
|
| Microfilament Proteins | 10 | 2007 | 485 | 0.460 |
Why?
|
| Genome | 2 | 2014 | 658 | 0.460 |
Why?
|
| Health | 1 | 2012 | 48 | 0.410 |
Why?
|
| Biodiversity | 1 | 2012 | 92 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 2003 | 176 | 0.400 |
Why?
|
| Genetic Markers | 8 | 2004 | 909 | 0.400 |
Why?
|
| Sequence Analysis, DNA | 11 | 2015 | 2437 | 0.390 |
Why?
|
| Wilms Tumor | 5 | 1996 | 287 | 0.390 |
Why?
|
| Beckwith-Wiedemann Syndrome | 4 | 1996 | 38 | 0.350 |
Why?
|
| Breast Neoplasms | 17 | 2009 | 15987 | 0.320 |
Why?
|
| Exome | 6 | 2013 | 1239 | 0.310 |
Why?
|
| Chromosome Deletion | 4 | 2003 | 1011 | 0.300 |
Why?
|
| Genes, Wilms Tumor | 3 | 1996 | 62 | 0.290 |
Why?
|
| Exons | 4 | 2012 | 1295 | 0.270 |
Why?
|
| Protein-Arginine N-Methyltransferases | 2 | 2005 | 219 | 0.270 |
Why?
|
| Genomics | 4 | 2015 | 2791 | 0.250 |
Why?
|
| Protein Methyltransferases | 1 | 2005 | 44 | 0.250 |
Why?
|
| Bees | 2 | 2015 | 31 | 0.240 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2002 | 81 | 0.240 |
Why?
|
| Molecular Sequence Data | 10 | 2015 | 5943 | 0.240 |
Why?
|
| Genes, Insect | 2 | 2015 | 129 | 0.230 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 1399 | 0.230 |
Why?
|
| Rectal Neoplasms | 1 | 2012 | 1220 | 0.230 |
Why?
|
| Gene Deletion | 6 | 2013 | 1441 | 0.220 |
Why?
|
| Introns | 4 | 2015 | 412 | 0.220 |
Why?
|
| Alleles | 5 | 2012 | 2354 | 0.220 |
Why?
|
| Microsatellite Repeats | 3 | 2003 | 588 | 0.210 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2013 | 87 | 0.200 |
Why?
|
| Translocation, Genetic | 4 | 1996 | 1261 | 0.200 |
Why?
|
| Nevus, Pigmented | 1 | 2002 | 105 | 0.200 |
Why?
|
| Chromosome Mapping | 10 | 2015 | 1412 | 0.200 |
Why?
|
| Carcinoma | 3 | 2011 | 2568 | 0.200 |
Why?
|
| Polymorphism, Restriction Fragment Length | 4 | 1996 | 230 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2002 | 284 | 0.190 |
Why?
|
| Rhabdomyosarcoma | 3 | 1996 | 342 | 0.190 |
Why?
|
| Blood Proteins | 1 | 2002 | 283 | 0.190 |
Why?
|
| Genome-Wide Association Study | 3 | 2014 | 2063 | 0.190 |
Why?
|
| Cytoskeletal Proteins | 2 | 2004 | 520 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2015 | 4254 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2002 | 322 | 0.180 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2012 | 496 | 0.180 |
Why?
|
| Genetic Heterogeneity | 1 | 2002 | 312 | 0.180 |
Why?
|
| Kidney Neoplasms | 5 | 1996 | 3075 | 0.180 |
Why?
|
| Base Sequence | 9 | 2011 | 4774 | 0.170 |
Why?
|
| Apoptosis | 4 | 2009 | 7642 | 0.170 |
Why?
|
| Mutation | 6 | 2012 | 15379 | 0.160 |
Why?
|
| Synteny | 2 | 2015 | 81 | 0.150 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 2 | 1996 | 77 | 0.150 |
Why?
|
| Open Reading Frames | 3 | 2015 | 239 | 0.150 |
Why?
|
| Autophagy | 3 | 2009 | 912 | 0.140 |
Why?
|
| Brain Neoplasms | 4 | 2003 | 4842 | 0.140 |
Why?
|
| Phosphoproteins | 1 | 2002 | 1154 | 0.140 |
Why?
|
| Cellular Senescence | 3 | 2009 | 383 | 0.130 |
Why?
|
| Proteins | 1 | 2004 | 1920 | 0.130 |
Why?
|
| Evolution, Molecular | 3 | 2015 | 834 | 0.130 |
Why?
|
| DNA Probes | 3 | 1995 | 213 | 0.130 |
Why?
|
| Humans | 47 | 2015 | 262965 | 0.130 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 4695 | 0.130 |
Why?
|
| Phylogeny | 2 | 2014 | 831 | 0.120 |
Why?
|
| Arthropods | 1 | 2014 | 27 | 0.120 |
Why?
|
| DNA Methylation | 4 | 2014 | 2694 | 0.120 |
Why?
|
| Mutation Rate | 2 | 2012 | 218 | 0.120 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 4159 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 8 | 2011 | 5456 | 0.120 |
Why?
|
| Female | 26 | 2015 | 143882 | 0.110 |
Why?
|
| Methylation | 2 | 2006 | 593 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1995 | 247 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1994 | 173 | 0.110 |
Why?
|
| Sequence Tagged Sites | 1 | 1993 | 33 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2003 | 133 | 0.110 |
Why?
|
| Social Behavior | 1 | 2015 | 297 | 0.110 |
Why?
|
| Caspase 3 | 4 | 2007 | 471 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2015 | 8936 | 0.100 |
Why?
|
| Neurofibromin 2 | 2 | 2002 | 40 | 0.100 |
Why?
|
| Cell Line, Tumor | 8 | 2015 | 14706 | 0.100 |
Why?
|
| Reproduction | 1 | 2014 | 253 | 0.100 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2011 | 19 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2006 | 1774 | 0.100 |
Why?
|
| Consensus Sequence | 1 | 2011 | 106 | 0.100 |
Why?
|
| Ecosystem | 1 | 2012 | 110 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2015 | 728 | 0.100 |
Why?
|
| Demography | 1 | 2013 | 429 | 0.100 |
Why?
|
| Skin Neoplasms | 2 | 2011 | 4696 | 0.100 |
Why?
|
| Malformations of Cortical Development | 1 | 2011 | 56 | 0.090 |
Why?
|
| Reference Standards | 1 | 2012 | 357 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2012 | 427 | 0.090 |
Why?
|
| Melanoma | 2 | 2011 | 5344 | 0.090 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 183 | 0.090 |
Why?
|
| Glioma | 1 | 2002 | 1907 | 0.090 |
Why?
|
| Protein Binding | 3 | 2015 | 3386 | 0.090 |
Why?
|
| Meningioma | 2 | 2003 | 293 | 0.090 |
Why?
|
| Ependymoma | 2 | 2003 | 262 | 0.090 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 335 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 334 | 0.090 |
Why?
|
| Base Pairing | 1 | 2010 | 70 | 0.090 |
Why?
|
| DNA, Neoplasm | 6 | 2004 | 1896 | 0.090 |
Why?
|
| Patient Care | 1 | 2011 | 147 | 0.090 |
Why?
|
| Dystonic Disorders | 1 | 2011 | 82 | 0.090 |
Why?
|
| Gene Frequency | 6 | 2011 | 1098 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 6 | 2003 | 3160 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2006 | 3522 | 0.090 |
Why?
|
| Hybrid Cells | 3 | 1996 | 113 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 5104 | 0.090 |
Why?
|
| Databases, Nucleic Acid | 1 | 2010 | 113 | 0.090 |
Why?
|
| MicroRNAs | 2 | 2014 | 2879 | 0.080 |
Why?
|
| RNA, Long Noncoding | 1 | 2015 | 612 | 0.080 |
Why?
|
| Heterozygote | 5 | 2011 | 987 | 0.080 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1993 | 544 | 0.080 |
Why?
|
| Meningeal Neoplasms | 2 | 2003 | 459 | 0.080 |
Why?
|
| Autistic Disorder | 1 | 2012 | 332 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2015 | 1531 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2011 | 818 | 0.080 |
Why?
|
| Aging | 2 | 2014 | 1499 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2014 | 715 | 0.080 |
Why?
|
| Polymorphism, Genetic | 4 | 2014 | 1390 | 0.070 |
Why?
|
| Animals | 11 | 2015 | 59504 | 0.070 |
Why?
|
| Male | 17 | 2015 | 124253 | 0.070 |
Why?
|
| Polyploidy | 1 | 2007 | 74 | 0.070 |
Why?
|
| Adult | 10 | 2014 | 78876 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2009 | 985 | 0.070 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1994 | 904 | 0.070 |
Why?
|
| Lung Neoplasms | 4 | 2004 | 11572 | 0.070 |
Why?
|
| Phenotype | 3 | 2012 | 6205 | 0.070 |
Why?
|
| Calcitriol | 1 | 2006 | 121 | 0.070 |
Why?
|
| Genome, Human | 2 | 2011 | 1802 | 0.070 |
Why?
|
| Genetic Variation | 4 | 2014 | 1989 | 0.070 |
Why?
|
| Immunoglobulins | 1 | 2007 | 264 | 0.070 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 817 | 0.070 |
Why?
|
| Caspase 8 | 1 | 2006 | 145 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1519 | 0.060 |
Why?
|
| Selenoproteins | 2 | 2015 | 16 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 2011 | 989 | 0.060 |
Why?
|
| S-Adenosylmethionine | 1 | 2004 | 44 | 0.060 |
Why?
|
| Interspersed Repetitive Sequences | 2 | 2015 | 34 | 0.060 |
Why?
|
| Adolescent | 5 | 2012 | 31597 | 0.060 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2004 | 167 | 0.060 |
Why?
|
| Sequence Deletion | 3 | 2011 | 864 | 0.060 |
Why?
|
| Transcription Factors | 4 | 2014 | 5243 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2005 | 541 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1444 | 0.060 |
Why?
|
| Cell Adhesion | 2 | 2007 | 982 | 0.060 |
Why?
|
| Alanine | 1 | 2004 | 240 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3241 | 0.060 |
Why?
|
| Cell Line | 2 | 2005 | 5001 | 0.060 |
Why?
|
| Young Adult | 2 | 2012 | 21764 | 0.060 |
Why?
|
| Radiation Tolerance | 1 | 2006 | 619 | 0.050 |
Why?
|
| Genomic Imprinting | 1 | 2004 | 186 | 0.050 |
Why?
|
| Pyrroles | 1 | 2007 | 581 | 0.050 |
Why?
|
| Serine | 1 | 2004 | 379 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2002 | 115 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2011 | 6047 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 1198 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 641 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 176 | 0.050 |
Why?
|
| Genes, p16 | 1 | 2002 | 130 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2013 | 5329 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 4821 | 0.050 |
Why?
|
| Caspases | 1 | 2004 | 674 | 0.050 |
Why?
|
| Electric Impedance | 1 | 2002 | 97 | 0.050 |
Why?
|
| Retroperitoneal Neoplasms | 2 | 1995 | 293 | 0.050 |
Why?
|
| Mammary Glands, Animal | 1 | 2005 | 542 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2002 | 445 | 0.050 |
Why?
|
| 14-3-3 Proteins | 1 | 2002 | 142 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2009 | 3071 | 0.050 |
Why?
|
| Cricetinae | 2 | 1994 | 680 | 0.050 |
Why?
|
| Databases, Genetic | 2 | 2015 | 727 | 0.050 |
Why?
|
| Methotrexate | 1 | 2004 | 1016 | 0.050 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2002 | 148 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 606 | 0.050 |
Why?
|
| Binding Sites | 1 | 2005 | 2124 | 0.050 |
Why?
|
| Probability | 1 | 2002 | 852 | 0.050 |
Why?
|
| Cell Division | 2 | 2002 | 2525 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 1162 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2002 | 830 | 0.040 |
Why?
|
| Neoplasm Metastasis | 2 | 2003 | 5206 | 0.040 |
Why?
|
| Linear Models | 1 | 2002 | 1056 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 1459 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 2831 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2013 | 5896 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2004 | 1065 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 2251 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 1377 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 5839 | 0.040 |
Why?
|
| Disease Progression | 3 | 2003 | 6746 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1995 | 350 | 0.040 |
Why?
|
| Transfection | 1 | 2002 | 2931 | 0.040 |
Why?
|
| Antineoplastic Agents | 3 | 2011 | 14445 | 0.030 |
Why?
|
| Aged | 5 | 2014 | 71343 | 0.030 |
Why?
|
| Kidney | 1 | 2005 | 2136 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2005 | 1454 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2006 | 3570 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 2366 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 1995 | 35 | 0.030 |
Why?
|
| Bee Venoms | 1 | 2015 | 9 | 0.030 |
Why?
|
| Chemoreceptor Cells | 1 | 2015 | 16 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1996 | 365 | 0.030 |
Why?
|
| Prognosis | 4 | 2003 | 22048 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2003 | 10180 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 3561 | 0.030 |
Why?
|
| Fibrocystic Breast Disease | 1 | 1995 | 46 | 0.030 |
Why?
|
| Adenosine Deaminase | 1 | 2015 | 94 | 0.030 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 10 | 0.030 |
Why?
|
| Middle Aged | 5 | 2014 | 87562 | 0.030 |
Why?
|
| Sex Chromosomes | 1 | 2014 | 39 | 0.030 |
Why?
|
| Receptors, Odorant | 1 | 2014 | 46 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 1912 | 0.030 |
Why?
|
| Genome, Mitochondrial | 1 | 2014 | 36 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 124 | 0.030 |
Why?
|
| Rhabdoid Tumor | 1 | 1995 | 109 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1995 | 169 | 0.030 |
Why?
|
| Registries | 1 | 2002 | 2191 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2004 | 5440 | 0.030 |
Why?
|
| Base Composition | 1 | 2014 | 86 | 0.030 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1994 | 129 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 741 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 5009 | 0.030 |
Why?
|
| Random Allocation | 1 | 1995 | 693 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 550 | 0.030 |
Why?
|
| CHO Cells | 1 | 1994 | 302 | 0.030 |
Why?
|
| Population Control | 1 | 2013 | 5 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 870 | 0.030 |
Why?
|
| Chromosome Aberrations | 2 | 2007 | 1960 | 0.030 |
Why?
|
| Hormones | 1 | 2014 | 270 | 0.030 |
Why?
|
| Multigene Family | 1 | 2014 | 415 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 194 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 238 | 0.030 |
Why?
|
| Child, Preschool | 4 | 2013 | 16398 | 0.030 |
Why?
|
| Chromosomes, Insect | 1 | 2012 | 8 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 527 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2012 | 82 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2014 | 972 | 0.030 |
Why?
|
| Starvation | 1 | 2012 | 26 | 0.030 |
Why?
|
| Child | 5 | 2013 | 29582 | 0.030 |
Why?
|
| Centromere | 1 | 2012 | 93 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 419 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2015 | 1601 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2013 | 195 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2011 | 342 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2011 | 46 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2012 | 145 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2012 | 180 | 0.020 |
Why?
|
| Globins | 1 | 1991 | 68 | 0.020 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 149 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2015 | 796 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2015 | 1825 | 0.020 |
Why?
|
| X Chromosome | 1 | 2012 | 334 | 0.020 |
Why?
|
| Levodopa | 1 | 2011 | 89 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 1465 | 0.020 |
Why?
|
| Pedigree | 2 | 2011 | 1842 | 0.020 |
Why?
|
| Family Health | 1 | 2012 | 309 | 0.020 |
Why?
|
| Cricetulus | 1 | 1991 | 197 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 1389 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2011 | 229 | 0.020 |
Why?
|
| Homozygote | 1 | 2013 | 722 | 0.020 |
Why?
|
| Oncogenes | 1 | 1994 | 671 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2014 | 871 | 0.020 |
Why?
|
| Solutions | 1 | 2010 | 103 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 675 | 0.020 |
Why?
|
| Siblings | 1 | 2011 | 287 | 0.020 |
Why?
|
| Cell Proliferation | 3 | 2007 | 7202 | 0.020 |
Why?
|
| Dacarbazine | 1 | 2011 | 483 | 0.020 |
Why?
|
| Craniofacial Abnormalities | 1 | 2011 | 245 | 0.020 |
Why?
|
| Gene Library | 1 | 2010 | 297 | 0.020 |
Why?
|
| Mice | 3 | 2005 | 34694 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 1275 | 0.020 |
Why?
|
| Telomere | 1 | 2012 | 508 | 0.020 |
Why?
|
| Lymphocytes | 2 | 2003 | 1200 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 822 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2012 | 1025 | 0.020 |
Why?
|
| Peptides | 1 | 2014 | 1451 | 0.020 |
Why?
|
| Glioblastoma | 1 | 1998 | 1735 | 0.020 |
Why?
|
| Time Factors | 2 | 2007 | 12676 | 0.020 |
Why?
|
| Haplotypes | 1 | 2010 | 802 | 0.020 |
Why?
|
| DNA Damage | 2 | 2006 | 1942 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2002 | 12972 | 0.020 |
Why?
|
| Cell Adhesion Molecule-1 | 1 | 2007 | 4 | 0.020 |
Why?
|
| Sulfites | 1 | 2007 | 44 | 0.020 |
Why?
|
| United States | 2 | 2002 | 15777 | 0.020 |
Why?
|
| Free Radicals | 1 | 2006 | 62 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 1552 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2014 | 9239 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 1995 | 4861 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3870 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2007 | 516 | 0.020 |
Why?
|
| Microtubules | 1 | 2007 | 262 | 0.020 |
Why?
|
| Software | 1 | 2013 | 1308 | 0.020 |
Why?
|
| Pregnancy, Animal | 1 | 2005 | 90 | 0.020 |
Why?
|
| Computational Biology | 1 | 2011 | 1249 | 0.020 |
Why?
|
| G1 Phase | 1 | 2005 | 293 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 629 | 0.010 |
Why?
|
| Lactation | 1 | 2005 | 219 | 0.010 |
Why?
|
| Dinucleotide Repeats | 1 | 2003 | 10 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 3949 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 565 | 0.010 |
Why?
|
| Genotype | 1 | 2012 | 3936 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1995 | 9153 | 0.010 |
Why?
|
| Decision Making | 1 | 2011 | 1300 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 524 | 0.010 |
Why?
|
| Cyclins | 1 | 2004 | 455 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2011 | 1637 | 0.010 |
Why?
|
| Intestinal Neoplasms | 1 | 2004 | 188 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2004 | 567 | 0.010 |
Why?
|
| Lasers | 1 | 2003 | 215 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 2058 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 7581 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 2312 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 980 | 0.010 |
Why?
|
| Infant | 3 | 2003 | 13478 | 0.010 |
Why?
|
| Colon | 1 | 2004 | 660 | 0.010 |
Why?
|
| beta Catenin | 1 | 2004 | 679 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1995 | 14838 | 0.010 |
Why?
|
| Azacitidine | 1 | 2007 | 1198 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 30262 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 6035 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2007 | 1430 | 0.010 |
Why?
|
| DNA Repair | 1 | 2006 | 1853 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2005 | 1798 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 1556 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 4839 | 0.010 |
Why?
|
| Bucladesine | 1 | 1996 | 28 | 0.010 |
Why?
|
| Butyric Acid | 1 | 1996 | 14 | 0.010 |
Why?
|
| Colforsin | 1 | 1996 | 62 | 0.010 |
Why?
|
| Myosin Light Chains | 1 | 1996 | 25 | 0.010 |
Why?
|
| Acetylcholinesterase | 1 | 1996 | 23 | 0.010 |
Why?
|
| Myogenic Regulatory Factors | 1 | 1996 | 32 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2011 | 33152 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2002 | 2239 | 0.010 |
Why?
|
| Epistasis, Genetic | 1 | 1996 | 107 | 0.010 |
Why?
|
| Butyrates | 1 | 1996 | 56 | 0.010 |
Why?
|
| Japan | 1 | 1996 | 215 | 0.010 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2003 | 998 | 0.010 |
Why?
|
| WT1 Proteins | 1 | 1996 | 107 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 17420 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 241 | 0.010 |
Why?
|
| Receptor, ErbB-2 | 1 | 2005 | 2602 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 7720 | 0.010 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1994 | 7 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 7037 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1994 | 68 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1996 | 519 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 5318 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1996 | 540 | 0.010 |
Why?
|
| Pregnancy | 1 | 2005 | 7523 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 8884 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2003 | 10023 | 0.010 |
Why?
|
| Reference Values | 1 | 1993 | 1089 | 0.010 |
Why?
|
| DNA Primers | 1 | 1993 | 1388 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 1994 | 576 | 0.010 |
Why?
|
| Carcinoma, Lobular | 1 | 1994 | 615 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 4062 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 12270 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2004 | 3572 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 13778 | 0.000 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1994 | 1215 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2005 | 11936 | 0.000 |
Why?
|
| Breast | 1 | 1993 | 1335 | 0.000 |
Why?
|
| Incidence | 1 | 1996 | 5705 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1996 | 4056 | 0.000 |
Why?
|
| DNA | 1 | 1993 | 2672 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2003 | 38849 | 0.000 |
Why?
|
| Neoplasms | 1 | 2003 | 15604 | 0.000 |
Why?
|